The use of levofloxacin in a patient with leptospirosis

Kaynakça (11)

1. Shalit I, Barnea A, Shahar A: Efficacy of ciprofloxacin againts interrogans serogroup icterohaemorrhagiae. Antimicrob Agents Chemother. 33: 788-789, 1989. Leptospira
2. Sünbül M: Leptospiroz. ANKEM Derg. 20 (Ek2): 219-221, 2006.
3. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM: Leptospirosis: a zoonotic disease of globalimportance. Lancet Infect Dis. 3: 757–771, 2003.
4. http://www.med.monash.edu.au/microbiol ogy/staff/adler/leptoguidelines2003pdf
5. Takashima I, Ngoma M, Hashimoto N: Antimicrobial effects of a new carboxyquinolone drug, Q-35, on five serogroups of Leptospira interrogans. Antimicrob Agents Chemother. 37: 901- 902, 1993.
6. Truccola J, Charavay F, Merien F, Perolat P: Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob Agents Chemother. 46: 848- 852, 2002.
7. Schonberg A: Studies on the effect of antibiotic substances on leptospires and their cultivation from material with a high bacterial count. Zentralbl Bacteriol A. 249: 400-406, 1981.
8. Sugunan AP, Natarajaseenivasan K, Vijayachari P, Seghal SC: Percutaneous exposure resulting in laboratory-acquired leptospirosis -a case report. J Med Microbiol. 53: 1258-1262, 2004.
9. Mancel E, Merrien F, Pesenti L, Salino D, Angibaud G, Perolat P: Clinical aspects of ocular leptospirosis in New Caledonia (South Pacific). Aust N Z J Ophthalmol. 27: 380– 386, 1999.
10. National Committee for Clinical Laboratory Standards: dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa,1997.
11. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM: Leptospirosis: a zoonotic disease of globalimportance. Lancet Infect Dis. 3: 757–771, 2003.